COVID-19 vaccine immunogenicity in people with HIV : AIDS COVID-19 vaccine immunogenicity
in people with HIV : AIDS Log in or Register Subscribe to journalSubscribe Get new issue …

People living with HIV (PLWH) may be at risk for poor immunogenicity to certain vaccines,
including the ability to develop immunological memory. Here, we assessed T-cell …

Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people with HIV (PWH). Here, we compare coronavirus disease 2019 (COVID …

Background Predictors of COVID-19 vaccine immunogenicity and the influence of prior
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection require …

Introduction More than 3 years into the pandemic, there is persisting uncertainty as to the
etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological …

COVID-19 breakthrough infection (BTI) can occur despite vaccination. Using a multi-centre,
prospective, observational Canadian cohort of people with HIV (PWH) receiving≥ 2 COVID …

Background Immune response to COVID-19 vaccine is diminished in patients with
hematologic malignancy. There is limited data regarding response to vaccine doses in these …

Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people living with HIV (PLWH). Here, we compare COVID-19 vaccine-induced …

Prevention of negative COVID19 infection outcomes and infection/vaccine-acquired
immunity is associated with the quality of antibody responses, whose variance by age and …

Introduction More than three years into the pandemic, there is persisting uncertainty as to the
etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological …